Imedra Healthcare (Pvt.) Ltd was established in 2017 to fill several gaps in the Sri Lankan market in terms of state-of-the-art pharmaceutical and healthcare products with the goal of improving the quality of life of Sri Lankans. Our product range includes pharmaceuticals, supplements and vitamins, personal protective equipment (PPE), surgical items, and beauty and skincare products.

Imedra Healthcare is proud to be the first company to introduce Empagliflozin – a drug used to treat Type 2 Diabetes – under the brand name “Empa”, produced by NIPRO JMI Pharma, a Japanese joint venture with Bangladesh. Empa quickly became the most trusted and prescribed brand in the market by 2019.

Imedra is the first to introduce a Microwave Tumour Ablation procedure in Sri Lanka in 2017, which has since helped patients fight several forms of cancer.

Imedra Healthcare takes pride in its strengths of building valuable partnerships within the pharmaceuticals and healthcare industries. Our distribution network exceeds 2,500 outlets, including pharmacies, medical institutions, and the State Pharmaceutical Corporation. We are also in collaboration with the Ministry of Health in Sri Lanka to achieve our goal of creating a healthier society in the country.